Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process and caprolactone. This segment's products are used in various applications comprising pavement preservation, pavement adhesion promotion and warm mix paving, oil well service additives, oil production and downstream application chemicals, printing inks, adhesives, agrochemicals, lubricants and industrial intermediates, coatings resins, elastomers, adhesives, and bio-plastics. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Phone843-740-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.13 billion
Profitability
Miscellaneous
Employees1,750
Next Earnings Date5/1/2019 (Estimated)
OptionableOptionable
Ingevity (NYSE:NGVT) Frequently Asked Questions
What is Ingevity's stock symbol?
Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."
How were Ingevity's earnings last quarter?
Ingevity Corp (NYSE:NGVT) posted its earnings results on Wednesday, February, 13th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.78 by $0.29. The business earned $278.60 million during the quarter, compared to analysts' expectations of $265.60 million. Ingevity had a return on equity of 53.18% and a net margin of 14.92%. Ingevity's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.45 EPS. View Ingevity's Earnings History.
When is Ingevity's next earnings date?
What guidance has Ingevity issued on next quarter's earnings?
Ingevity issued an update on its FY19 earnings guidance on Wednesday, February, 13th. The company provided earnings per share (EPS) guidance of ~5.16 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.71. The company issued revenue guidance of $1.3-1.36 billion, compared to the consensus revenue estimate of $1.23 billion.Ingevity also updated its FY 2019 guidance to EPS.
What price target have analysts set for NGVT?
8 equities research analysts have issued 1-year target prices for Ingevity's stock. Their predictions range from $68.00 to $110.00. On average, they expect Ingevity's stock price to reach $97.25 in the next twelve months. This suggests that the stock has a possible downside of 8.4%. View Analyst Price Targets for Ingevity.
What is the consensus analysts' recommendation for Ingevity?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.
Has Ingevity been receiving favorable news coverage?
News stories about NGVT stock have been trending positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Ingevity earned a news impact score of 3.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term.
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include ASAHI KASEI COR/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), W. R. Grace & Co (GRA), Huntsman (HUN), Ashland Global (ASH), KURARAY CO LTD/ADR (KURRY), Olin (OLN), Univar (UNVR), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), Innospec (IOSP) and KMG Chemicals (KMG).
What other stocks do shareholders of Ingevity own?
Who are Ingevity's key executives?
Ingevity's management team includes the folowing people:
- Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)
- Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)
- Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)
- Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)
- Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58)
Who are Ingevity's major shareholders?
Ingevity's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.43%), FMR LLC (1.94%), Massachusetts Financial Services Co. MA (1.81%), Channing Capital Management LLC (1.73%), Bank of New York Mellon Corp (1.51%) and Northern Trust Corp (1.35%). Company insiders that own Ingevity stock include Jean S Blackwell, John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Institutional Ownership Trends for Ingevity.
Which major investors are selling Ingevity stock?
NGVT stock was sold by a variety of institutional investors in the last quarter, including Castleark Management LLC, Copper Rock Capital Partners LLC, Kornitzer Capital Management Inc. KS, FMR LLC, Mesirow Financial Investment Management Equity Management, Two Sigma Advisers LP, London Co. of Virginia and BlackRock Inc.. Company insiders that have sold Ingevity company stock in the last year include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Insider Buying and Selling for Ingevity.
Which major investors are buying Ingevity stock?
NGVT stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Victory Capital Management Inc., Braun Stacey Associates Inc., Massachusetts Financial Services Co. MA, Dimensional Fund Advisors LP, Channing Capital Management LLC, Nuveen Asset Management LLC and SG Americas Securities LLC. View Insider Buying and Selling for Ingevity.
How do I buy shares of Ingevity?
Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ingevity's stock price today?
One share of NGVT stock can currently be purchased for approximately $106.20.
How big of a company is Ingevity?
Ingevity has a market capitalization of $4.43 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,750 workers across the globe.
What is Ingevity's official website?
How can I contact Ingevity?
Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]
MarketBeat Community Rating for Ingevity (NYSE NGVT)
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
